1-(3-methylphenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid, 250mg

1-(3-thienyl)ethanamine, 95.0%, 10g

1-Methyl-3-(3-(triethoxysilyl)propyl)-1H-imidazol-3-ium chloride, 98%, 25g

(S)-tert-Butyl 2-(2-hydroxyethyl)morpholine-4-carboxylate, 97%, 100mg

Succinic acid, min. 99%, for synthesis, , 2.5 kg, plastic packaging.

5-Chloro-1-methylpyrazin-2(1H)-one, 98%, 1g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket GL connecting piece, DN 150, 4000 ml, 190 mm, 1 Piece

1,3,4-oxadiazol-2-ol, 95.0%, 10g

TLC Plates SIL G-25, 20 x 20 cm, 25 Piece(s)

3-(Thiophene-2-amido)benzoic acid, 97%, 500mg

(2E)-3-(4-bromophenyl)-1-(2,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

(4-Phenylthiazol-2-yl)methanamine, 95.0%, 250mg

3-Methylpyridazine, 95.0%, 5g